anti-VEGF mAb (Shandong Quangang Pharmaceutical)

N/A

Report date: 2025/03/14 16:29:16

Base Information

Drug Nameanti-VEGF mAb (Shandong Quangang Pharmaceutical)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionVascular endothelial growth factor receptor antagonists
TargetsVascular endothelial growth factor receptor
Therapy Area/Indications +[1]  N/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShandong Quangang Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Quangang Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications +[1]  N/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A